Emerging biomarker p-Tau181 is linked to tau pathology, and neurofilament light chain (NfL) reflect axonal damage, when combined enhance diagnostic accuracy and provide a comprehensive understanding of AD pathology (13). This evidence concerns the gene MAPT and Alzheimer disease.